Table 5. Clinical trials with the AKT inhibitor MK-2206 in head and neck cancer patients.
| Compound | Combination | Phase | State | NCT number |
|---|---|---|---|---|
| MK-2206 | / | 2 | Completed | NCT01349933 |
| / | 2 | Completed | NCT01370070 |
NCT: Number clinicaltrials.gov identifier.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.